Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2359064 | 0.81 | ALDH1A1 (0.43) | ALDH1A1 | |
| SCHEMBL238158 | 0.76 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL5968591 | 0.74 | EGLN1 (0.39) | ALDH1A1 | |
| SCHEMBL5785545 | 0.74 | ALDH1A1 (0.38) | ALDH1A1 | |
| SCHEMBL515928 | 0.74 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL731664 | 0.74 | ALDH1A1 (0.46) | ALDH1A1 | |
| SCHEMBL781568 | 0.72 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL10972290 | 0.72 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL733088 | 0.72 | ALDH1A1 (0.62) | ALDH1A1 | |
| SCHEMBL1768486 | 0.72 | ALDH1A1 (0.34) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100221749-A1 | THREE-FUNCTIONAL PSEUDO-PEPTIDIC REAGENT, AND USES AND APPLICATIONS THEREOF | UNIVERSITE DE ROUEN | 2010-09-02 | — | — | US | claimed |
| US-10260056-B2 | Cleavage of fucose in N-glycans | NEW ENGLAND BIOLABS, INC. (US) | 2019-04-16 | — | — | US | disclosed |
| US-20180265854-A1 | Cleavage of Fucose in N-Glycans | NEW ENGLAND BIOLABS, INC. (US) | 2018-09-20 | — | — | US | disclosed |
| EP-2252584-B1 | COMPOUNDS AND METHODS FOR RAPID LABELING OF N-GLYCANS | PROZYME INC (US) | 2016-12-07 | — | — | EP | disclosed |
| EP-2317307-B1 | Method of analyzing amino- and/or imino-functional compounds, and analytical reagent | AJINOMOTO KK (JP) | 2013-11-20 | — | — | EP | disclosed |
| US-8445292-B2 | Compounds and methods for rapid labeling of N-glycans | PROZYME, INC. (US) | 2013-05-21 | — | — | US | disclosed |
| US-20120107942-A1 | COMPOUNDS AND METHODS FOR RAPID LABELING OF N-GLYCANS | PROZYME, INC. (US) | 2012-05-03 | — | — | US | disclosed |
| US-8124792-B2 | Compounds and methods for rapid labeling of N-glycans | PROZYME, INC. (US) | 2012-02-28 | — | — | US | disclosed |
| EP-2338057-A1 | MASS MARKERS AND METHODS | Brax Limited (GB) | 2011-06-29 | — | — | EP | disclosed |
| US-20110152119-A1 | Quantification Method of Biochemical Substances Using Ion Scattering Spectroscopy and Specific-Binding Efficiency Quantification Method of Biochemical Substances Using Ion Scattering Spectroscopy | KOREA RESEARCH INSTITUTE OF STANDARDS AND SCIENCE (KR) | 2011-06-23 | — | — | US | disclosed |
| US-20110143951-A1 | MASS MARKERS AND METHODS | BRAX LIMITED (GB) | 2011-06-16 | — | — | US | disclosed |
| EP-2252584-A1 | COMPOUNDS AND METHODS FOR RAPID LABELING OF N-GLYCANS | Prozyme, Inc. (US) | 2010-11-24 | — | — | EP | disclosed |
| US-20100221749-A1 | THREE-FUNCTIONAL PSEUDO-PEPTIDIC REAGENT, AND USES AND APPLICATIONS THEREOF | UNIVERSITE DE ROUEN | 2010-09-02 | — | — | US | disclosed |
| WO-2010021509-A2 | QUANTIFICATION METHOD OF BIOCHEMICAL SUBSTANCES USING ION SCATTERING SPECTROSCOPY AND SPECIFIC-BINDING EFFICIENCY QUANTIFICATION METHOD OF BIOCHEMICAL SUBSTANCES USING ION SCATTERING SPECTROSCOPY | KOREA RESEARCH INSTITUTE OF STANDARDS AND SCIENCE (KR) | 2010-02-25 | — | — | WO | disclosed |
| WO-2009153577-A1 | MASS MARKERS AND METHODS | BRAX LIMITED (GB) | 2009-12-23 | — | — | WO | disclosed |
| US-20090258437-A1 | COMPOUNDS AND METHODS FOR RAPID LABELING OF N-GLYCANS | PROZYME, INC. (US) | 2009-10-15 | — | — | US | disclosed |
| WO-2009100155-A1 | COMPOUNDS AND METHODS FOR RAPID LABELING OF N-GLYCANS | PROZYME, INC. (US) | 2009-08-13 | — | — | WO | disclosed |
| EP-1252186-A2 | USE OF NEUREGULIN-BETA AS AN INDICATOR AND/OR TARGET | ProteoSys AG (DE) | 2002-10-30 | — | — | EP | disclosed |
| WO-2001058948-A2 | USE OF NEUREGULIN-β AS AN INDICATOR AND/OR TARGET | PROTEOSYS AG (DE) | 2001-08-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110143951-A1 | MASS MARKERS AND METHODS | PTMS, DCLRE1A, DCLRE1B | ALDH1A1 3900/4885 |
| US-20090258437-A1 | COMPOUNDS AND METHODS FOR RAPID LABELING OF N-GLYCANS | B3GNT2, FUT5, FUT6 | ALDH1A1 2931/4885 |
| US-20100221749-A1 | THREE-FUNCTIONAL PSEUDO-PEPTIDIC REAGENT, AND USES AND APPLICATIONS THEREOF | DNPEP, PEPD, LNPEP | ALDH1A1 2974/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.